A Phase I/ II Feasibility Study of Intravenous Cetuximab in Combination with 5 days Weekly Oral Capecitabine and Preoperative Radiotherapy in Rectal Cancer (XERXES). (2020). Archives of Clinical and Biomedical Research, 4(4), 394-412. https://fortunejournals.org/ojs/index.php/acbr/article/view/14778